OmicsEdge

OmicsEdge is a precision medicine company that utilizes advanced genomic analytics and artificial intelligence to optimize drug development and clinical trial outcomes. The company specializes in the application of polygenic risk scores (PRS) to identify high-risk patient cohorts and predict treatment response across various therapeutic areas, including cardiovascular and metabolic diseases. By integrating multi-omics data, OmicsEdge enables pharmaceutical companies to enrich clinical trials with patients most likely to demonstrate efficacy, thereby increasing the probability of technical and regulatory success. Their platform also supports the development of companion diagnostics to guide personalized treatment decisions in clinical practice.